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The past decade has seen an appreciation of the critical biological significance of 
glycosylation and the impact that glycans can have on the efficacy, stability and 
immunogenicity of important glycoproteins. For the biopharma industry the level of 
product characterization and process monitoring demanded, particularly in the context of 
glycosylation, is set to increase and will become an even more significant issue with the 
entry of biosimilar products into the biopharmaceutical arena.  In order to meet these 
demands of the regulatory biopharmaceutical and generic producers alike require rapid , 
sensitive and high throughput techniques to enable detailed glycoprotein separation and 
analysis. It is extremely difficult to separate closely related glycoforms using standard 
chromatographic methods, such as ion exchange chromatography (IEX), gel exclusion 
chromatography (GEC) and hydrophobic interaction chromatography (HIC). 
Here , we report the development of a series of new bio-affinity based phases that are 
capable of separating closely related glycoproteins/glycoproteins. These phases get their 
selectivity from a number of recombinant prokaryotic bioligands called lectins. Lectins 
are proteins that are capable of recognizing and binding reversibly to specific  
glycan structures. While lectin binding affinities for monosaccharides are generally low 
they bind to disaccharides and more complex oligosaccharide structures with 
significantly higher affinities and exquisite specificity.  
We have identified, cloned , expressed and purified a series of novel and specific lectin 
proteins from prokaryotic sources. We have immobilized them onto a number of novel 
platforms in order to develop a variety of bioaffinity phases. We have interrogated these 
new bioaffinity phases with various mixtures of closely related glycoproteins and 
glycoconjugates. We have demonstrated the selective elution of the bound glycoforms 
from these bioaffinity phases using different combinations of free and modified sugars 
and that these new phases have the ability to efficiently separate very closely related 
glycoforms.  
 
